Quantcast
Home / Practice Areas / Business and Civil Practice / Justice Dept. joins Risperdal whistleblower suits

Justice Dept. joins Risperdal whistleblower suits

The U.S. Attorney's office in Boston announced that the Justice Department has filed a False Claims Act complaint against Johnson & Johnson and two subsidiaries for allegedly paying millions of dollars in kickbacks to nursing homes to prescribe its anti-psychotic drug Risperdal.